Gradel, K.O.; Nørgård, B.M.; Friedman, S.; Kjeldsen, J.; Larsen, M.D.
Longitudinal Measurements of Blood Biomarkers in Patients with Crohn’s Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment Failure. J. Clin. Med. 2024, 13, 926.
https://doi.org/10.3390/jcm13040926
AMA Style
Gradel KO, Nørgård BM, Friedman S, Kjeldsen J, Larsen MD.
Longitudinal Measurements of Blood Biomarkers in Patients with Crohn’s Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment Failure. Journal of Clinical Medicine. 2024; 13(4):926.
https://doi.org/10.3390/jcm13040926
Chicago/Turabian Style
Gradel, Kim Oren, Bente Mertz Nørgård, Sonia Friedman, Jens Kjeldsen, and Michael Due Larsen.
2024. "Longitudinal Measurements of Blood Biomarkers in Patients with Crohn’s Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment Failure" Journal of Clinical Medicine 13, no. 4: 926.
https://doi.org/10.3390/jcm13040926
APA Style
Gradel, K. O., Nørgård, B. M., Friedman, S., Kjeldsen, J., & Larsen, M. D.
(2024). Longitudinal Measurements of Blood Biomarkers in Patients with Crohn’s Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment Failure. Journal of Clinical Medicine, 13(4), 926.
https://doi.org/10.3390/jcm13040926
